Gphl involved in medical equipment manufacturing and marketing through test

Recently, Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Guangzhou Baiyun Mountain") and the United States Medical Holdings Co., Ltd. (hereinafter referred to as the "beauty of Health) in the Guangzhou municipal government formally signed a letter of intent, the parties intend to set up a joint venture company, to create high-end medical equipment R & D and production base. Although there are escort policy, Guangzhou Baiyun Mountain and also in the field of high-end medical equipment plays an important role, but whether it can be successfully fulfilled remains to be the market test.

Involved in medical device manufacturing

Not only meet in medical equipment wholesale, sales, import and export business, the Guangzhou Baiyun Mountain and started the layout of the high-end medical equipment R & D and production. According to the Guangzhou Baiyunshan Pharmaceutical released announcement, the company and the United States Medical signed "cooperation agreement", the two sides agreed to joint venture to build high-end NMR production base in Guangzhou Development Zone location, projects with a total investment of about 3 billion yuan, which Guangzhou Baiyunshan Pharmaceutical in cash funded accounted for 60% of the shares; when the United States medical to "cash + technology" funded accounted for 40% of the shares. The first phase of the production of pediatric and Department of orthopedics professional MR machine based.

Announcement shows that the two sides will make full use of their respective advantages, including Guangzhou Baiyunshan Pharmaceutical in the capital, sales network advantage, beauty medical in new technology, new products, and other advantages, expand medical equipment business. Specifically in the capital, the advantages of sales reflected in the post, after the completion of the development and production of product sales channels how to get through these become more concerned about the current hot issues. Guangzhou Baiyunshan Pharmaceutical related personnel told the Beijing Daily reporter, at present the company just has intention and signed the agreement, but later how to put R & D and production and post production sales channels etc. and now there is no specific plans.

It is understood that the United States is a medical treatment with independent intellectual property rights of high-end medical diagnostic equipment R & D and manufacturing enterprises, is one of the world's cutting-edge medical imaging technology innovation company. Beauty medical commitment to provide customers with perfect medical imaging solutions, including medical imaging system in magnetic resonance imaging (MRI) systems, computed tomography imaging system (CT), digital X-ray system (DR) development, design, manufacturing, sales and service.

"Although and beauty medical to reach an agreement, but in my opinion beauty health does not provide to the core technology of the Guangzhou Baiyun Mountain and some high-end medical equipment. So if you want to layout the field of nuclear magnetic resonance still need to buy the core technology to foreign companies, so that the cost of production and technology will increase." An unnamed expert said.

Beijing Daily reporter survey found that medical pharmaceutical companies are keen to "people" in. Kang Chi Pharmaceutical (300086, Guba) January 4, and Beijing HENGZHUO Technology Holdings Co., Ltd. signed a contract through the love of the promotion of acoustic benefits artificial cochlea, and jointly promote the cochlear implant technology development in the domestic market. Kang Chi pharmaceutical chairman Hong Jiangyou said, the major cooperation is Kang Chi pharmaceutical research in the field of medical equipment layout. Kang Chi pharmaceutical will give full play to their own resources and the advantages of traditional channels, and Hengzhou technical Qiangqiang jointly, in terms of market development, product promotion, terminal construction and so on to reach a win-win situation, through the love of acoustic benefits cochlear implant technology, more people with hearing loss especially hearing-impaired children to bring the gospel ".

Qianshan medicine machine (300216, Guba) announcement released earlier, the aim market of medical apparatus and instruments issued nearly 40 billion yuan in additional plans.

Double temptation by policy profits

Medical device market outlook is very good has become an open secret. Public data shows, medical devices and diagnostic reagent Market in China's average annual growth rate can be reached more than 25%, higher than the growth of the pharmaceutical industry, but in the medical devices in China accounted for only about 13% of the pharmaceutical industry sales revenue, far below the overall level of about 50% of the Europe and the United States, has a huge market potential.

In addition, the Beijing Daily reporter access to information found that only in 2015 the state issued a 18 relevant policies to support the development of domestic medical equipment. Including, May 9, 2015, the general office of the State Council "on the issuance of deepening the reform of the medical and health system summary of work in 2014 and 2015 key tasks notice" (Guo Ban Fa [2015] No. 34), summarize the achievement in 2014 mentioned, continue to strengthen the investment to create new drugs and medical equipment localization technology, research to promote the localization of medical apparatus and instruments of policy measures.

In August 18, 2015, the State Council issued the "opinions on reforming the examination and approval system of medical devices for drugs and medical devices" (hereinafter referred to as "opinions"). "Opinions" pointed out that to encourage medical equipment research and innovation, will have the core technology invention patents, has significant clinical value of innovative medical devices registration application for inclusion in the scope of special review approval, be handled in priority. Timely revision of standard medical equipment, improve the international standards of medical devices adoption rate, improve the domestic medical device product quality.

Beijing Ding Chen pharmaceutical management consulting center, said Shi Lichen, the 18 policies are mainly in the following several leading direction, the first is the procurement, especially large equipment procurement must be based on the domestic. The second is to encourage domestic medical equipment R & D and production technology to improve. The third is the basic unit of medical units to the introduction or elimination of medical equipment updates. And the three directions of the integration for the domestic production of medical equipment enterprises to provide a considerable market.

Tsinghua University Research Center for healthcare management, foreign economic and Trade University China Economic Development Research Center researcher Cao Jian in an interview also said, which cause the policy support and itself large enough market and the temptation of profit of a large number of companies have flocked to join the production field of a medical appliance.

Faced with the test of production and marketing difficulties

Although in Guangzhou Baiyun Mountain View, relying on its own funds, network marketing advantages, plus beauty medical advantage in new technologies and new products to have the confidence to expand medical equipment business, but the reality does not seem to go well. Data show that magnetic resonance technology since its inception, global only three large superconducting magnet factory, Ge, Siemens, Philips, the three magnetic resonance equipment of leading enterprises in almost a monopoly of the magnetic resonance imaging technology.

The 2014 China Medical equipment service survey report "(hereinafter referred to as the" report ") has shown, CT, nuclear magnetic resonance, nuclear medicine, angiography, in a few large medical equipment, is known in the industry as" GPS "Ge, Philips, Siemens, three multinational enterprises in industry occupies a market share of more than 80%.

Data released by the China Medical Equipment Association in 2015 showed that in 2012 SIEMENS and general electric, PHILPS's share of China's high-end medical equipment market more than 70% of the share.

From the perspective of the three enterprises the advantages of their products, Ge in CT, ultrasound imaging, nuclear medicine three types of equipment market possession rate ranked first; Philips in angiography machine, digital X - ray imaging system two kinds of equipment of market possession rate ranked in the first place; Siemens a list of magnetic resonance equipment.

That is to say, first of all, the problem from the core technology in the production of gphl Baiyun Mountain will. "In general, the domestic enterprises to produce high-end medical equipment is not a problem, but the core component is the need to buy foreign enterprises, so it will increase production costs and technical costs. High costs will affect the price of finished products, pricing is too high will not be accepted, the price is too low and will make their profits lower." Shi Lichen said.

Market recognition needs to be improved

For the use of medical devices in the hospital, the Beijing Business Daily reporter contacted the Shaanxi University of traditional Chinese Medicine Affiliated Hospital Associate Professor, deputy director of the physician Dong sheng. "Our hospital use of nuclear magnetic resonance equipment and other medical equipment is mainly SIEMENS, the quality of domestic equipment remains to be improved. Local enterprises are able to produce medical equipment, but the important part of the equipment made technology is not." Dong Sheng admits. In addition, the 309 Hospital, Beijing, when talking about medical equipment, hospitals in the procurement of the time to consider the level of more, and the core technology is a very important part of the device.

In addition, in Shi Lichen's view, the biggest problem is the high-end gphl Baiyun Mountain Road Sales channels. Although the state has formally issued medical units in the procurement of medical equipment must be dominated by domestic, Guangzhou Baiyunshan Pharmaceutical Policy in this seemingly large sales market, but Neusoft and other large medical equipment manufacturing enterprises has been firmly occupy the previous position, the Guangzhou Baiyun Mountain and want to squeeze is difficult.

Altogether, under the policy support of the domestic medical equipment market prospects, Guangzhou Baiyun Mountain and want in this field points a cup of soup is understandable, but want to in high-end medical equipment on the road to go long, go for a long time to overcome production costs, production technology, sales prices, profit margins and sales channel five questions.

In fact, in did not grasp the core technology of countries stipulate that the procurement must be dominated by domestic for many hospitals shouted is hiding something. The domestic medical equipment purchasing price than foreign products is a lot of benefits, but later prone to quality problems, and these problems domestic manufacturers no technology can be repaired, only the replacement of the core components, and as a result the follow-up maintenance costs will naturally increase. In addition, medical devices currently used in domestic hospitals especially high-end medical equipment basically all rely on the import, policies issued after the hospital to purchase domestic equipment, then docking interface and data equipment is able to success is also worry about hospital.